Table 1.
Gene (OMIM) | Disease (OMIM) | Inheritance | Origin of Podocyte Models |
---|---|---|---|
ACTN4 (604638) | Focal segmental glomerulosclerosis 1 (603278) | AD | |
ANLN (616027) | Focal segmental glomerulosclerosis 8 (616032) | AD | |
APOL1 (603743) | Focal segmental glomerulosclerosis 4, susceptibility to (612551) | ||
ARHGAP24 (610586) | Focal segmental glomerulosclerosis | AD |
|
ARHGDIA (601925) | Steroid resistant nephrotic syndrome, type 8 (615244) | AR | |
AVIL (613397) | Steroid resistant nephrotic syndrome, type 21 (618594) | AR |
|
CD2AP (604241) | Focal segmental glomerulosclerosis, 3 (607832) | AD | |
CDC42 (116952) | Takenouchi–Kosaki syndrome (616737) | AD |
|
CDK20 (610076) | Steroid resistant nephrotic syndrome | AR |
|
CLCN5 (300008) | Dent disease (300009) | XLR |
|
COL4A3 (120070) | Alport syndrome 2 (203780) Alport syndrome 3 (104200) |
AR AD |
|
COL4A4 (120131) | Alport syndrome 2 (203780) | AR | |
COL4A5 (303630) | Alport syndrome 1, X-linked (301050) | XLD | |
COQ6 (614647) | Coenzyme Q10 deficiency, primary, 6 (614650) | AR | |
COQ8B (615567) | Steroid resistant nephrotic syndrome, type 9 (615573) | AR | |
CRB2 (609720) | Focal segmental glomerulosclerosis 9 (616220) | AR |
|
CTNS (606272) | Nephropathic cystinosis (219800) | AR | |
CUBN (602997) | Proteinuria, chronic benign (618884) | AR |
|
DAAM2 (606627) | Steroid resistant nephrotic syndrome | AR |
|
DGKE (601440) | Steroid resistant nephrotic syndrome, 7 (615008) | AR |
|
DLC1 (604258) | Steroid resistant nephrotic syndrome | AR |
|
EMP2 (602334) | Steroid resistant nephrotic syndrome, 10 (615861) | AR | |
FAT1 (600976) | Glomerulotubular nephropathy | AR |
|
GLA (300644) | Fabry disease (301500) | XL | |
INF2 (610982) | Focal segmental glomerulosclerosis, 5 (613237) | AD | |
ITGA3 (605025) | Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital (614748) | AR |
|
ITSN1 (602442) | Steroid resistant nephrotic syndrome | AR |
|
ITSN2 (604464) | Steroid resistant nephrotic syndrome | AR |
|
KANK1 (607704) | Cerebral palsy, spastic quadriplegic, 2 (612900) | AD/AR |
|
KANK2 (614610) | Steroid resistant nephrotic syndrome, 16 (617783) | AR |
|
KANK4 (614612) | Steroid resistant nephrotic syndrome | AR |
|
LAGE3 (300060) | Galloway–Mowat syndrome 2 (301006) | XLR |
|
LAMB2 (150325) | Steroid resistant nephrotic syndrome, type 5, with or without ocular abnormalities (614199) | AR |
|
LMX1B (602575) | Focal segmental glomerulosclerosis 10 (256020) Nail-patella syndrome (161200) |
AD AD |
|
MAGI2 (606382) | Steroid resistant nephrotic syndrome, type 15 (617609) | AR |
|
MYH9 (160775) | Macrothrombocytopenia and granulocyte inclusions with nephritis (155100) | AD | |
MYO1E (601479) | Focal segmental glomerulosclerosis, 6 (614131) | AR | |
MYO9A (604875) | Focal segmental glomerulosclerosis | AD |
|
NPHS1 (602716) | Steroid resistant nephrotic syndrome, type 1 (256300) | AR |
|
NPHS2 (604766) | Steroid resistant nephrotic syndrome, type 2 (600995) | AR | |
NUP85 (170285) | Steroid resistant nephrotic syndrome, type 17 (618176) | AR |
|
NUP93 (614351) | Steroid resistant nephrotic syndrome, type 12 (616892) | AR |
|
NUP107 (607617) | Steroid resistant nephrotic syndrome, type 11 (616730) Galloway–Mowat syndrome 7 (618348) |
AR AR |
|
NUP133 (607613) | Steroid resistant nephrotic syndrome, type 18 (618177) Galloway–Mowat syndrome 8 (618349) |
AR AR |
|
NUP160 (607614) | Steroid resistant nephrotic syndrome, type 19 (618178) | AR |
|
NUP205 (614352) | Steroid resistant nephrotic syndrome, type 13 (616893) | AR |
|
OSGEP (610107) | Galloway–Mowat syndrome 3 (617729) | AR |
|
PAX2 (167409) | Focal segmental glomerulosclerosis, 7 (616002) | AD |
|
PDSS2 (610564) | Coenzyme Q10 deficiency, primary, 3 (614652) | AR |
|
PLCE1 (608414) | Steroid resistant nephrotic syndrome, type 3 (610725) | AR |
|
PODXL (602632) | Focal segmental glomerulosclerosis | AD/AR |
|
SGPL1 (603729) | Steroid resistant nephrotic syndrome, type 14 (617575) | AR |
|
SYNPO | Steroid resistant nephrotic syndrome | AR | |
TBC1D8B (301027) | Steroid resistant nephrotic syndrome, type 20 (301028) | XL | |
TNS2 (607717) | Steroid resistant nephrotic syndrome | AR |
|
TP53RK (608679) | Galloway–Mowat syndrome 4 (617730) | AR |
|
TPRKB (608680) | Galloway–Mowat syndrome 5 (617731) | AR |
|
TRPC6 (603652) | Glomerulosclerosis, focal segmental, 2 (603965) | AD | |
TTC21B (612014) | Nephronophthisis 12 (613820) | AD/AR |
|
WDR73 (616144) | Galloway–Mowat syndrome 1 (251300) | AR | |
WT1 (607102) | Steroid resistant nephrotic, type 4 (256370) | AD |
|
XPO5 (607845) | Steroid resistant nephrotic syndrome | AR |
|
AD, autosomal dominant; AR, autosomal recessive; XL, X-linked.